Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.

Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.



СІМЕЙНІ ЛІКАРІ ТА ТЕРАПЕВТИ

НЕВРОЛОГИ, НЕЙРОХІРУРГИ, ЛІКАРІ ЗАГАЛЬНОЇ ПРАКТИКИ, СІМЕЙНІ ЛІКАРІ

КАРДІОЛОГИ, СІМЕЙНІ ЛІКАРІ, РЕВМАТОЛОГИ, НЕВРОЛОГИ, ЕНДОКРИНОЛОГИ

СТОМАТОЛОГИ

ІНФЕКЦІОНІСТИ, СІМЕЙНІ ЛІКАРІ, ПЕДІАТРИ, ГАСТРОЕНТЕРОЛОГИ, ГЕПАТОЛОГИ

ТРАВМАТОЛОГИ

ОНКОЛОГИ, (ОНКО-ГЕМАТОЛОГИ, ХІМІОТЕРАПЕВТИ, МАМОЛОГИ, ОНКО-ХІРУРГИ)

ЕНДОКРИНОЛОГИ, СІМЕЙНІ ЛІКАРІ, ПЕДІАТРИ, КАРДІОЛОГИ ТА ІНШІ СПЕЦІАЛІСТИ

ПЕДІАТРИ ТА СІМЕЙНІ ЛІКАРІ

АНЕСТЕЗІОЛОГИ, ХІРУРГИ

International journal of endocrinology 1 (65) 2015

Back to issue

Results of cohort study of parathyroiod gland function dynamics in patients with secondary hyperparathyroidism

Authors: Karlovich N. V. - EE "Belarusian state medical University", "City endocrinological dispensary", Minsk

Categories: Endocrinology

Sections: Clinical researches

print version


Keywords

secondary hyperparathyroidism, dialysis patients.

The aim: to estimate dynamics of parathyroid gland function in patients with end-stage chronic kidney disease on dialysis during period of observation from 5 to 24 months and to determine factors of secondary hyperparathyroidism progression.

Methods. 92 dialysis patients were examined, 40 males, 52 females; age 47.2±11.4yrs; dialysis duration 4.9±3.9 yrs; mean observational period 8.9±4.3 months (5-24). Serum PTH, 25(OH)D3, osteocalcin (OC), C-terminal telopeptide of type I collagen (beta-CTx), alkaline phosphotase (ALP), calcium (Ca) and phosphorus (P) were measured initially and at the end of observation. All patients were recommended to follow low-phosphate diet and 74.4% received calcium carbonate.

Results. PTH level was 559.6±552.5 initially and 603.9±581.6pg/ml at the end of observation, p=0.251. Frequency of high, normal uremic and low PTH levels was 55.4% vs 7.6%, 20.7% vs 21.7%, 23.9% vs 20.7%, respectively (p>0.05). P decreased from 2.34±0.67 to 2.14±0.60 mmol/l, p=0.0003. In patients with initial hypercalcemia PTH increased from 525.3±518.4 to 616.2±606.2 pg/ml, p=0.03. PTH level at the end of observation correlate with age (r=-0.25), OC (r=0.58), beta-CTx (r=0.76) and ALP (r=0.40). Strong correlation was found with the initial PTH (r=0.84). At the end of observation PTH decreased in 40pts (43.5%), mean decrease 204.6±250.1 pg/ml; increased in 52 patients (56.5%), mean increase 235.6±274.5 pg/ml. Subgroups with decreased and increased PTH didn’t show differences of demographic data, levels of Ca, P and bone turnover markers. Comparison of initial and repeated PTH level in subgroups with duration of observation 6, 9, 12, >12 months didn’t reveal significant changes.

Conclusions. In dialysis patients with stable parameters of Ca, P and bone turnover markers in the absence of therapeutic intervention of secondary hyperparathyroidism PTH level remains unchanged during period of observation up to 12 months and even more. In such patients reasonable interval of PTH measurement should be once per year. Initial level of PTH is the most important predictor of parathyroid function dynamics. Young age, high Ca, P and bone turnover markers levels are another factors influencing secondary hyperparathyroidism progression.



Back to issue